Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / phenergan attending: addendum: this is an addendum to the discharge summary of from . discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 3. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 4. paroxetine hcl 20 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 5. atorvastatin 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po every 4-6 hours as needed for pain. disp:*40 tablet(s)* refills:*0* 7. amiodarone 200 mg tablet sig: one (1) tablet po every eight (8) hours for 4 days: then decrease to 200 mg twice daily for 1 week, then 200 mg daily for 1 month, then discontinue. disp:*60 tablet(s)* refills:*0* 8. plavix 75 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 9. insulin lisp & lisp prot (hum) 100 unit/ml (75-25) suspension sig: as directed units subcutaneous twice a day: 15 units before breakfast, 10 units before dinner. disp:*1 vial* refills:*2* 10. insulin regular human 100 unit/ml solution sig: as directed units injection four times a day: sliding scale as directed. disp:*1 vial* refills:*2* 11. furosemide 40 mg tablet sig: one (1) tablet po twice a day for 2 weeks: then decrease to daily. disp:*60 tablet(s)* refills:*2* 12. toprol xl 50 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po once a day. disp:*30 tablet sustained release 24 hr(s)* refills:*2* 13. potassium chloride 20 meq packet sig: one (1) packet po once a day. disp:*30 packet(s)* refills:*2* 14. warfarin 1 mg tablet sig: three (3) tablet po once (once) for 2 days: 2mg today, & tomorrow, , then inr to be checked and called to dr. for continued dosing, for target inr 2.0-2.5. disp:*60 tablet(s)* refills:*0* discharge disposition: extended care facility: health care center md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified (aorto)coronary bypass of three coronary arteries single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery coronary arteriography using two catheters left heart cardiac catheterization enteral infusion of concentrated nutritional substances initial insertion of dual-chamber device initial insertion of transvenous leads [electrodes] into atrium and ventricle other and unspecified repair of atrial septal defect artificial pacemaker rate check diagnoses: hyperpotassemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery esophageal reflux pure hypercholesterolemia urinary tract infection, site not specified congestive heart failure, unspecified hyposmolality and/or hyponatremia cardiac complications, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified diaphragmatic hernia without mention of obstruction or gangrene anxiety state, unspecified ostium secundum type atrial septal defect osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of noncompliance with medical treatment, presenting hazards to health sinoatrial node dysfunction background diabetic retinopathy nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] diabetes with ketoacidosis, type ii or unspecified type, uncontrolled diabetes with renal manifestations, type ii or unspecified type, uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled 

Answer: The patient is high likely exposed to